Status:

UNKNOWN

Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Lead Sponsor:

MGC Pharmaceuticals d.o.o

Conditions:

Corona Virus Infection

Covid19

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

A preparation of CimertrA, comprising Artemisinin, Curcumin, and Boswellia, and Vitamin C in a nanoparticular formulation, is proposed as a treatment for the disease associated with the novel coronavi...

Detailed Description

The study will take place during the patient's hospitalization due to a COVID-19 infection. The study will last up to 4 weeks, until the conclusion on day 28. In case of hospital discharge within the ...

Eligibility Criteria

Inclusion

  • Confirmed SARS-CoV-2 infection (according to nationally authorized laboratory criteria)
  • Hospitalized patient with COVID-19 of moderate stable or worsening severity not requiring ICU admission.
  • Age: 18 years old and above.
  • Subjects must be under observation or admitted to a controlled facility or hospital (home quarantine is not sufficient).
  • Ability to receive treatment by spray into the oral cavity

Exclusion

  • Tube feeding or parenteral nutrition.
  • Patients with scores 5 or above per the Ordinal Scale for Clinical Improvement published by the WHO. (i.e., who need oxygen supply beyond use of nozzles or simple mask)
  • Need for admission to ICU during the present hospitalization at any time prior to completion of the recruitment to the study.
  • Any condition which, in the opinion of the Principal Investigator, would prevent full participation in this trial or would interfere with the evaluation of the trial endpoints.

Key Trial Info

Start Date :

June 11 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2023

Estimated Enrollment :

252 Patients enrolled

Trial Details

Trial ID

NCT04802382

Start Date

June 11 2021

End Date

April 1 2023

Last Update

August 24 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Nazareth Hospital EMMS

Nazareth, North, Israel

2

Rambam Medical Center

Haifa, Israel